aws SEED!
We are excited to announce that bespark*bio has successfully secured Seed funding from aws (Austria Wirtschaftsservice), marking a major milestone in our journey!
We shape your journey from scientific breakthrough to clinical development by creating leading-edge production processes.
Our production processes unleash the power of viral vectors, bionanoparticles and biologics to address the most pressing medical challenges of our time.
Our production processes unleash the power of viral vectors, bionanoparticles and biologics to address the most pressing medical challenges of our time.
Effective development is paramount for optimizing process efficiency, robustness, scalability, and product quality.
bespark*bio’s advanced process development solutions combine best-in-class bioprocessing expertise and state-of the-art technology with contemporary digitalization and machine-learning approaches.
Modular building blocks and pre-established framework technologies reduce complexity and offer adaptable resources that serve as launch pad for process customization.
By harnessing these methodologies, we expedite process development, reduce cost, increase process understanding and ultimately mitigate risk of failure.